Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.40 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.38 |
| ▸ | SULT1E1 | P49888 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | CDC25A | P30304 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26472022 | 0.84 | ALDH1A1 (0.53) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL4456739 | 0.83 | ALDH1A1 (0.60) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL19766903 | 0.81 | ALDH1A1 (0.51) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL26472020 | 0.77 | ALDH1A1 (0.55) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL2784576 | 0.77 | ALDH1A1 (0.55) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL17301626 | 0.77 | ALDH1A1 (0.50) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| Rotundifuran SCHEMBL6233092 | 0.75 | ALDH1A1 (0.56) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL13446720 | 0.74 | ALDH1A1 (0.72) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL13446726 | 0.74 | ALDH1A1 (0.72) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL30525934 | 0.70 | ALDH1A1 (0.47) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658087-A1 | ANIMAL FEED ADDITIVE COMPOSITIONS AND METHODS OF USE | PMI Nutrition, LLC (US) | 2025-12-10 | — | — | EP | claimed |
| US-20240268416-A1 | ANIMAL FEED ADDITIVE COMPOSITIONS AND METHODS OF USE | PMI NUTRITION LLC (US) | 2024-08-15 | — | — | US | claimed |
| WO-2024163291-A1 | ANIMAL FEED ADDITIVE COMPOSITIONS AND METHODS OF USE | PMI NUTRITION, LLC (US) | 2024-08-08 | — | — | WO | claimed |
| EP-4408188-A1 | FEED ADDITIVE COMPOSITIONS AND METHODS | PMI Nutrition, LLC (US) | 2024-08-07 | — | — | EP | claimed |
| CN-118175934-A | Feed additive composition and method | 普密艾营养有限公司 | 2024-06-11 | — | — | CN | claimed |
| US-20230381135-A1 | COMPOSITION COMPRISING AT LEAST ONE LABDANE DITERPENE AND METHOD FOR MANUFACTURING SAME | ELEONOR (BE) | 2023-11-30 | — | — | US | claimed |
| EP-4228604-A1 | COMPOSITION COMPRISING AT LEAST ONE LABDANE DITERPENE AND METHOD FOR MANUFACTURING SAME | Tilman (BE) | 2023-08-23 | — | — | EP | claimed |
| US-20230134934-A1 | FEED ADDITIVE COMPOSITIONS AND METHODS | PMI NUTRITION LLC (US) | 2023-05-04 | — | — | US | claimed |
| WO-2023056376-A1 | FEED ADDITIVE COMPOSITIONS AND METHODS | PMI NUTRITION, LLC (US) | 2023-04-06 | — | — | WO | claimed |
| WO-2022079090-A1 | COMPOSITION COMPRISING AT LEAST ONE LABDANE DITERPENE AND METHOD FOR MANUFACTURING SAME | TILMAN SA (BE) | 2022-04-21 | — | — | WO | claimed |
| EP-1915166-B1 | MARRUBIIN AND COMPOSITION FOR REDUCING SNORING, PACKAGE AND METHOD | PURANOX MEDICAL B V (NL) | 2009-05-20 | — | — | EP | claimed |
| EP-4658087-A1 | ANIMAL FEED ADDITIVE COMPOSITIONS AND METHODS OF USE | PMI Nutrition, LLC (US) | 2025-12-10 | — | — | EP | disclosed |
| US-20250098710-A1 | FEED ADDITIVE COMPOSITIONS AND METHODS | PMI NUTRITION LLC (US) | 2025-03-27 | — | — | US | disclosed |
| US-12193457-B2 | Feed additive compositions and methods | PMI NUTRITION, LLC (US) | 2025-01-14 | — | — | US | disclosed |
| US-20240268416-A1 | ANIMAL FEED ADDITIVE COMPOSITIONS AND METHODS OF USE | PMI NUTRITION LLC (US) | 2024-08-15 | — | — | US | disclosed |
| EP-1915166-B1 | MARRUBIIN AND COMPOSITION FOR REDUCING SNORING, PACKAGE AND METHOD | PURANOX MEDICAL B V (NL) | 2009-05-20 | — | — | EP | disclosed |
| US-20080305192-A1 | Marrubiin and Composition For Reducing Snoring, Package and Method | PURANOX MEDICAL B.V. (NL) | 2008-12-11 | — | — | US | disclosed |
| CN-101257913-A | Marrubiin and composition for reducing snoring, package and method | PURANOX MEDICAL B V (NL) | 2008-09-03 | — | — | CN | disclosed |
| EP-1915166-A2 | MARRUBIIN AND COMPOSITION FOR REDUCING SNORING, PACKAGE AND METHOD | Puranox Medical B.V. (NL) | 2008-04-30 | — | — | EP | disclosed |
| WO-2007018432-A2 | MARRUBIIN AND COMPOSITION FOR REDUCING SNORING, PACKAGE AND METHOD | PURANOX MEDICAL B.V. (NL) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080305192-A1 | Marrubiin and Composition For Reducing Snoring, Package and Method | NISCH, UTRN, MTPN | ALDH1A1 1660/4885MAPT 4300/4885USP2 3949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.